相关实验视频

Updated: May 6, 2026

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

在有脑外转移的质母细胞瘤中,需要多学科治疗

Niklas B Pepper¹, David R Steike², Heidi Yppärilä-Wolters²

¹Department of Radiation Oncology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany. Niklas.pepper@ukmuenster.de.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

|January 22, 2025

概括

脑外质母细胞瘤的表现很少见,但可能发生,导致患者的快速衰退. 息治疗和以患者为中心的决策对于管理这种侵袭性脑瘤至关重要.

科学领域:

神经瘤学神经瘤学
在瘤学瘤学.
病理学病理学病理学

背景情况:

质母细胞瘤是成年人中最常见的原发性恶性脑瘤.
脑外质母细胞瘤的表现非常罕见.
质母细胞瘤带来了一个糟糕的预后.

研究的目的:

审查关于脑外质母细胞瘤表现的文献.
介绍一个患有质母细胞瘤和脑外扩散的病例研究.
为了突出管理晚期质母细胞瘤的挑战.

主要方法:

对PubMed数据库的系统文献审查.
包括一种具有脑外扩散的质母细胞瘤临床病例.
对治疗反应和患者结果的分析.

主要成果:

一名60岁的女性患者患有质母细胞瘤,发生了广泛的内进展.
脑外转移出现在骨,腺,淋巴结和肺部.
尽管多式治疗,患者的病情迅速恶化,导致诊断后12个月死亡.

结论:

脑外扩散意味着晚期质母细胞瘤预后不佳.
管理需要密切合作和以患者为中心的息策略.
多学科决策对于优化患者护理至关重要.

关键词:

轴外表现的表现方式高度质瘤高度质瘤抚慰性护理是一项非常重要的护理.放射化疗是一种放射性化疗.辐射疗法辐射疗法

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

相关概念视频

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...